Search Results

The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.

140 Results Found

AHA, Associations, Hospitals Respond to Government in 340B Supreme Court Case

The government does not dispute that the agency singled out Section 340B hospitals as a group and set their reimbursement based on acquisition cost rather than price, without conducting the cost study that the statute requires. The agency’s action was therefore contrary to law.
Public

Court Opinion in Sanofi-Aventis U.S., LLC, and Novo Nordisk Challenges to 340B Contract Pharmacies Obligations

November 5, 2021 UNITED STATES DISTRICT COURT DISTRICT OF NEW JERSEY
Public

Court Opinion in Novartis/United Therapeutics Challenges to 340B Contract Pharmacies Obligations (November 5, 2021)

This case concerns conditions that plaintiffs Novartis Pharmaceuticals Corporation and United Therapeutics Corporation have imposed on discounted drug purchases by certain safetynet health care providers.
Public

Court Order Novartis/United Therapeutics Challenges to 340B Contract Pharmacies Obligations (November 5, 2021

ORDERED that the plaintiffs' Motions for Summary Judgment, Dkt. 19 (Novartis), Dkt. 14 (United Therapeutics) are GRANTED IN PART and DENIED IN PART.
Public

Court Order in the Lilly Challenge October 29, 2021

Court Order in the Lilly Challenge October 29, 2021
Public

Court Decision on the Lilly Challenge October 29, 2021

Court Decision on the Lilly Challenge October 29, 2021
Public

Government Responds to Hospital 340B Payment Reduction Challenge (Oct. 20, 2021)

Government responds to Hospital 340B Payment Reduction Challenge (Oct. 20, 2021).
Public

AHA, National Associations Amicus Brief – 340B Contact Pharmacy Legal Challenge by Sanofi - June 15, 2021

The 340B program, established by section 340B of the Public Health Service Act, 42 U.S.C. § 256b, requires as a condition of participating in Medicaid and Medicare Part B that pharmaceutical manufacturers sell outpatient drugs at a discounted price to certain public and not-for-profit hospitals, community health centers, and other providers that serve patients with low incomes (340B providers or covered entities).
Public

Amicus Brief: State and Regional Hospital Associations Express Support for AHA’s 340B Case September 9, 2021

At a Glance Amici curiae are 37 non-profit state and regional hospital associations. They represent thousands of hospitals and health systems across the United States.

AHA Opening Brief in Case Urging U.S. Supreme Court to Reverse Cut to 340B Program

The AHA urged The Supreme Court of the United States to reverse the 2020 federal appeals court decision that upheld the authority of the Department of Health and Human Services to significantly cut payments to certain hospitals that participate in the 340B Drug Pricing Program.